raw materials – Page 16

Labeling mismatch detected during dispensing – root cause analysis for mix-ups

Root Cause Analysis for Labeling Mismatch Scenarios During Dispensing Labeling mismatches detected during dispensing present significant risks in pharmaceutical manufacturing, potentially leading to product recalls, regulatory scrutiny, and compromised patient…

Sampling SOP not followed during incoming material receipt – GMP expectations for material sampling

Addressing Deviations from Material Sampling SOP during Incoming Material Receipt The adherence to standard operating procedures (SOPs) is critical in pharmaceutical manufacturing, particularly in the context of incoming raw material…

Traceability records incomplete during dispensing – preventing repeat mix-up events

Preventing Repeat Mix-Up Events with Incomplete Traceability Records During Dispensing Material traceability is a critical aspect of pharmaceutical manufacturing, particularly during the dispensing phase. Incomplete traceability records can lead to…

Improper sample storage during deviation investigation – CAPA to prevent recurrence

Understanding Improper Sample Storage in Deviation Investigations and CAPA Implementation In the pharmaceutical industry, proper sample storage is crucial for the integrity of raw materials and the quality of finished…

Segregation controls inadequate during investigation – root cause analysis for mix-ups

Addressing Inadequate Segregation Controls During Investigations for Mix-Ups Mix-ups in pharmaceutical manufacturing can have severe consequences, which makes identifying the root causes and implementing effective prevention strategies vital. This playbook…

Improper sample storage during regulatory inspection – CAPA to prevent recurrence

Addressing Improper Sample Storage Observations During Regulatory Inspections During regulatory inspections, improper sample storage can trigger critical observations that not only compromise product quality but also weaken the company’s standing…

Traceability records incomplete during investigation – preventing repeat mix-up events

Managing Incomplete Traceability Records During Investigations to Prevent Mix-Up Events In the landscape of pharmaceutical manufacturing, the integrity of raw material traceability is paramount. Incomplete traceability records during investigations can…

Sampler training deficiency during supplier complaint review – GMP expectations for material sampling

Understanding Sampler Training Deficiency During Supplier Complaint Reviews In pharmaceutical manufacturing, the integrity of raw material sampling is critical to ensuring product quality and compliance with regulatory requirements. A common…

Barcode system failure during warehouse operations – traceability system expectations

Effective Playbook for Addressing Barcode System Failures in Warehouse Operations In the complex environment of pharmaceutical manufacturing, a barcode system failure can lead to significant disruptions, impacting the traceability of…

Improper sample storage during deviation investigation – preventing false OOS results

Addressing Improper Sample Storage in Deviation Investigations to Avoid False OOS Results In the pharmaceutical manufacturing industry, the integrity of raw materials is vital for ensuring product quality. Improper sample…

Material mix-up incident reported during audit – preventing repeat mix-up events

Addressing Material Mix-Up Incidents: A Comprehensive Playbook for Pharmaceutical Professionals Material mix-up incidents during audits can pose significant risks to product quality and regulatory compliance. These incidents can lead to…

Non-representative sampling detected during incoming material receipt – preventing false OOS results

Understanding Non-Representative Sampling During Incoming Material Receipt to Avoid False OOS Results In the highly regulated pharmaceutical environment, ensuring the integrity of raw materials through accurate sampling is crucial. Non-representative…